Cadrenal Therapeutics, Inc. (CVKD) — Dilution Risk Analysis
Current Snapshot
Cadrenal Therapeutics, Inc. (CVKD) has a DilutionWatch score of 74/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 74/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 8-K 2, SC 13G 1, EFFECT 1, 4 6.
| Form | Filed | Accession |
|---|---|---|
| 8-K | 2026-09-29 | 0001213900-26-104647 |
| SC 13G | 2026-08-07 | 0001193125-26-339234 |
| EFFECT | 2026-07-20 | 9999999995-26-002367 |
| 8-K | 2026-07-01 | 0001213900-26-074421 |
| 4 | 2026-07-01 | 0001213900-26-074557 |
| 4 | 2026-06-26 | 0001213900-26-072789 |
| 4 | 2026-06-24 | 0001213900-26-071578 |
| 4 | 2026-06-18 | 0001213900-26-070248 |
| 4 | 2026-06-15 | 0001213900-26-068981 |
| 4 | 2026-06-10 | 0001213900-26-067484 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 2 months | Source |
| Three-year share count growth | 119.16% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 74/10) Source
- Cash Runway
- 2 months Source
- Share Count Growth (3-Year)
- 119.16% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.